Literature DB >> 8959830

Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection.

I Lautenschlager1, K Höckerstedt, E Taskinen, E von Willebrand.   

Abstract

Vascular adhesion molecules and their ligands are important in leukocyte-endothelial cell interactions and in T-cell activation of rejection cascade. Also, cytomegalovirus (CMV) infection is suggested to be involved in the mechanisms of rejection. In this study, the expression of vascular adhesion molecules ICAM-1, VCAM-1 and ELAM-1 in the liver allografts, the number of leukocytes positive for their ligands LFA-1, VLA-4 and SLex, and activation markers (class II, IL2-receptor) were investigated in liver allografts during CMV infection and acute rejection and compared to grafts with normal function and histology. The adhesion molecules, their ligands and activation markers were demonstrated from liver biopsy frozen sections by the immunoperoxidase technique and monoclonal antibodies. A significant induction of ICAM-1 and VCAM-1 was seen in vascular and sinusoidal endothelium associated with both CMV and rejection, and induction of ELAM-1 in vascular endothelium in rejection only. In both cases, the number of leukocytes expressing LFA-1 was significantly increased, but VLA-4-positive cells were more characteristic for CMV and SLex-positive cells more for rejection. IL2-receptor positivity was practically seen in rejection only, but class II-expressing cells were increased during both CMV infection and rejection. In conclusion, adhesion molecules were induced and the infiltrating cells expressed their ligands both in liver rejection and during CMV infection, although the expression pattern was slightly different.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959830     DOI: 10.1007/978-3-662-00818-8_54

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  9 in total

1.  Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.

Authors:  T Martelius; M Salmi; H Wu; C Bruggeman; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis.

Authors:  Anatol Panasiuk; Jolanta Wysocka; Elzbieta Maciorkowska; Bozena Panasiuk; Danuta Prokopowicz; Janusz Zak; Karol Radomski
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent.

Authors:  C Söderberg-Nauclér; D N Streblow; K N Fish; J Allan-Yorke; P P Smith; J A Nelson
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection.

Authors:  Timi Martelius; Ville Salaspuro; Marko Salmi; Leena Krogerus; Krister Höckerstedt; Sirpa Jalkanen; Irmeli Lautenschlager
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 5.  Cytomegalovirus and chronic allograft rejection in liver transplantation.

Authors:  Liang-Hui Gao; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

6.  Cytomegalovirus-induced immunopathology and its clinical consequences.

Authors:  Stefania Varani; Maria Paola Landini
Journal:  Herpesviridae       Date:  2011-04-07

7.  Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.

Authors:  Roberta Angioni; Bianca Calì; Vasanthy Vigneswara; Marika Crescenzi; Ana Merino; Ricardo Sánchez-Rodríguez; Cristina Liboni; Martin J Hoogduijn; Philip Noel Newsome; Maurizio Muraca; Francesco Paolo Russo; Antonella Viola
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 8.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

Review 9.  Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.

Authors:  Deok-Hoon Kong; Young Kwan Kim; Mi Ra Kim; Ji Hye Jang; Sukmook Lee
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.